110060-70-3

Upstream product

• 52085-14-0 4-benzoxy-salicylaldehyde 
• 105-36-2 ethyl bromoacetate 
• 122443-91-8 diethyl 6-(benzyloxy)-3-hydroxybenzofuran-2,2(3H)-dicarboxylate 
• 412300-65-3 4-benzyloxy-2-[ethyloxycarbonylmethoxy]benzaldehyde 

Downstream Products

• 93877-72-6 2-(6-benzyloxy-benzofuran-2-yl)-propan-2-ol 
• 906448-92-8 6-hydroxy-benzofuran-2-carboxylic acid ethyl ester 
• 568594-14-9 (6-(benzyloxy)benzofuran-2-yl)methanol 
• 13196-11-7 6-hydroxybenzofuran 

Relevant academic research and scientific papers

ANTIFUNGAL AGENT CONTAINING PYRIDINE DERIVATIVE

The present invention provides an antifungal agent that has superior antifungal action and is also superior in terms of physical properties, safety and metabolic stability. The present invention discloses a compound represented by the formula (I): (wherein X represents an oxygen atom, a sulfur atom or -NH-, R1 represents a hydrogen atom, a halogen atom, a cyano group, an amino group or a substituent, and R2 and R3 independently represent a hydrogen atom, a halogen atom, a hydroxyl group or a substituent, except for a case in which R2 and R3 are both hydrogen atoms), and an antifungal agent containing the above compound.

VITAMIN D RECEPTOR MODULATORS

The present invention relates to novel, non-secosteroidal, phenyl-benzofuran compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.